Hello, Reader. For all that artificial intelligence has accomplished over the last few years, one thing it has not yet ...

CHICAGO -- Gene therapy for Danon disease, a rare inherited cause of hypertrophic cardiomyopathy, appeared to improve or ...

Bristol Myers reports promising preliminary results for its next-gen CAR T therapy CC-97540, showing safety and early efficacy in a Phase 1 study for severe autoimmune diseases.

AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically ...

With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...

For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure ...

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...